文献速递腹部泌尿生殖PETCT

68Ga-PSMA-11 PET/CT参数用于识别原发性透明细胞肾细胞癌PBRM1状态

Exploration of 68Ga-labelled prostate-specific membrane antigen-11 PET/CT parameters for identifying PBRM1 status in primary clear cell renal cell carcinoma.
PubMed 文献 · Clin Radiol · 2023-02-01

回顾性纳入41例原发性透明细胞肾细胞癌患者,术前行68Ga-PSMA-11 PET/CT,分析影像参数与PBRM1缺陷状态的关系。PBRM1缺陷组肿瘤直径和SUVmax显著不同,多因素分析显示SUVmax是识别PBRM1缺陷肿瘤的显著预测因子。PBRM1缺陷肿瘤趋向于伴更多细胞毒性T细胞浸润但多处于耗竭状态。

要点

  • SUVmax是多因素分析中识别PBRM1缺陷ccRCC的显著预测因子。
  • PBRM1缺陷与PBRM1保留组间肿瘤直径和SUVmax差异显著,CT衰减值无差异。
  • PBRM1缺陷肿瘤趋向更多细胞毒性T细胞浸润但多处于耗竭状态。

关键影像表现/征象

  • PBRM1缺陷与PBRM1保留组间肿瘤直径和SUVmax差异显著。
  • 两组间CT衰减值无差异。
  • PBRM1缺陷肿瘤趋向于伴更多细胞毒性T细胞浸润,但多数处于耗竭状态。

诊断标准与关键数值

  • SUVmax在多因素logistic回归中是识别PBRM1缺陷肿瘤的显著预测因子。
  • PBRM1缺陷状态由免疫组化和多重免疫荧光染色评估。

临床应用与阅片要点

  • 阅片时可关注SUVmax和肿瘤直径,辅助提示PBRM1缺陷可能。
  • CT衰减值在本研究中无鉴别价值,不应单独用于判断PBRM1状态。

局限性

  • 回顾性研究,样本量41例,单中心设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the predictive value of 68Ga-labelled prostate-specific membrane antigen-11 (68Ga-PSMA-11) integrated positron-emission tomography (PET)/computed tomography (CT) in PBRM1-deficient clear cell renal cell carcinoma (ccRCC).

MATERIALS AND METHODS: A total of 41 patients with ccRCC, were enrolled retrospectively and underwent 68Ga-PSMA-11 PET/CT preoperatively. Radiological parameters, including CT attenuation value and maximum standard uptake value (SUVmax), were derived. Immunohistochemical and multiple immunofluorescences staining were performed to evaluate the PBRM1 status and immune response. The predictive value of imaging factors was analysed using a receiver operator characteristic curve analysis. Univariate and multivariate logistic regression analyses were used to investigate the relationship between clinical and radiological variables and PBRM1 status.

RESULTS: A total of 41 patients were included in this study, with 14 patients having PBRM1-deficient status. The tumour diameter on imaging and SUVmax differed significantly in patients with different PBRM1 expression statuses and no difference in CT attenuation was identified. Univariate and multivariate logistic regression analyses showed SUVmax was an obvious predictor for identification of PBRM1-deficient tumours. In addition, PBRM1-deficient tumours tended to be accompanied by greater cytotoxic T-cell infiltration, although most of them were in an exhausted state.

CONCLUSIONS: 68Ga-PSMA-11 PET/CT could be used to discriminate invasive PBRM1-deficient ccRCC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Wang, Deng, Xu, et al. Exploration of 68Ga-labelled prostate-specific membrane antigen-11 PET/CT parameters for identifying PBRM1 status in primary clear cell renal cell carcinoma. Clin Radiol. 2023. PMID: 36805287. doi:10.1016/j.crad.2023.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。